Safety and Feasibility of Riociguat Therapy for the Treatment of Chronic Pulmonary Arterial Hypertension in Infancy

被引：9
|
作者：
Giesinger, Regan E. [1 ]
Stanford, Amy H. [1 ]
Thomas, Brady [1 ]
Abman, Steven H. [2 ]
McNamara, Patrick J. [1 ]
机构：
[1] Univ Iowa, Dept Pediat, Iowa City, IA USA
[2] Univ Colorado, Dept Pediat, Denver, CO USA
来源：
JOURNAL OF PEDIATRICS | 2023年 / 255卷
关键词：
SOLUBLE GUANYLATE-CYCLASE; BRONCHOPULMONARY DYSPLASIA; ECHOCARDIOGRAPHY; SILDENAFIL; DISEASE;
D O I：
10.1016/j.jpeds.2022.11.026
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The effects of riociguat, an oral-soluble guanylate-cyclase stimulator, were studied in 10 infants with chronic pulmonary arterial hypertension. Respiratory status (n = 8/10), right heart dilation (n = 7/10), function (n = 9/10), and chronic pulmonary arterial hypertension (n = 8/10) improved. Median decrement in systolic (12 [4, 14]), diastolic (14 [7, 20]), and mean arterial (14 [10, 17]) pressures were noted; no critical hypotension or hypoxemia occurred.
引用
收藏
页码：224 / +
页数：7
相关论文
共 50 条
  • [1] RIOCIGUAT FOR THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Larche, N. E.
    Mousa, S. A.
    DRUGS OF TODAY, 2013, 49 (12) : 761 - 768
  • [2] A focus on riociguat in the treatment of pulmonary arterial hypertension
    Toxvig, Anne Kathrine
    Wehland, Markus
    Grimm, Daniela
    Infanger, Manfred
    Krueger, Marcus
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 (03) : 202 - 214
  • [3] Riociguat in the Treatment of Pulmonary Arterial Hypertension
    Jerjes-Sanchez, Carlos
    Glenn-Valdez, Hector
    Zayas, Nayeli
    Cueto-Robledo, Guillermo
    Bonola, Liliana
    Pech-Alonso, Baltazar
    Ramirez, Alicia
    Flores-Puente, Fernando
    Garcia-Aguilar, Humberto
    Espitia-Hernandez, Guadalupe
    Prisciliano Montes, Guillermo
    Pulido, Tomas
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (04) : 352 - 358
  • [4] Riociguat for the Treatment of Pulmonary Arterial Hypertension
    Ghofrani, Hossein-Ardeschir
    Galie, Nazzareno
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne M.
    Langleben, David
    Kilama, Michael Ochan
    Fritsch, Arno
    Neuser, Dieter
    Rubin, Lewis J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04) : 330 - 340
  • [5] Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Bishop, Bryan M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (21) : 1839 - 1844
  • [6] Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Benza, Raymond L.
    Langleben, David
    Hemnes, Anna R.
    Noordegraaf, Anton Vonk
    Rosenkranz, Stephan
    Thenappan, Thenappan
    Hassoun, Paul M.
    Preston, Ioana R.
    Ghio, Stefano
    Badagliacca, Roberto
    Vizza, Carmine D.
    Lang, Irene M.
    Meier, Christian
    Gruenig, Ekkehard
    EUROPEAN RESPIRATORY REVIEW, 2022, 31 (166)
  • [7] Riociguat for the treatment of pulmonary hypertension
    Schermuly, Ralph T.
    Janssen, Wiebke
    Weissmann, Norbert
    Stasch, Johannes-Peter
    Grimminger, Friedrich
    Ghofrani, Hossein Ardeschir
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (04) : 567 - 576
  • [8] Riociguat for the treatment of pulmonary hypertension
    Hambly, Nathan
    Granton, John
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (06) : 679 - 695
  • [9] Riociguat for the treatment of pulmonary hypertension
    Meis, Tobias
    Behr, Juergen
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (16) : 2419 - 2427
  • [10] Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
    Ghofrani, Hossein-Ardeschir
    D'Armini, Andrea M.
    Grimminger, Friedrich
    Hoeper, Marius M.
    Jansa, Pavel
    Kim, Nick H.
    Mayer, Eckhard
    Simonneau, Gerald
    Wilkins, Martin R.
    Fritsch, Arno
    Neuser, Dieter
    Weimann, Gerrit
    Wang, Chen
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04) : 319 - 329
12345